4.4 Article Proceedings Paper

Impacts of Initial Prescription Length and Prescribing Limits on Risk of Prolonged Postsurgical Opioid Use

期刊

MEDICAL CARE
卷 60, 期 1, 页码 75-82

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MLR.0000000000001663

关键词

opioids; surgery; prescription limits; prolonged use

资金

  1. National Research Service Award Pre-Doctoral/Post-Doctoral Traineeship from the Agency for Healthcare Research and Quality - The Cecil G. Sheps Center for Health Services Research, The University of North Carolina at Chapel Hill [T32-HS000032]
  2. Pharmacoepidemiology Gillings Innovation Lab (PEGIL) for the Population-Based Evaluation of Drug Benefits and Harms in Older US Adults [GIL200811.0010]
  3. Center for Pharmacoepidemiology, Department of Epidemiology, UNC Gillings School of Global Public Health
  4. CER Strategic Initiative of UNC's Clinical Translational Science Award [UL1TR002489]
  5. Cecil G. Sheps Center for Health Services Research, UNC
  6. UNC School of Medicine
  7. NIH/NIDA [R36 DA04588501]
  8. US Food and Drug Administration [HHSF223201810183C, FDA: 75F40119C10115]
  9. National Institute on Aging (NIA) [R01 HL118255, R01MD011680, R01 AG056479]
  10. National Institutes of Health (NIH) [R01 HL118255, R01MD011680]
  11. National Heart, Lung, and Blood Institute [NHLBI: R01 HL118255]
  12. UNC Clinical and Translational Science Award [UL1TR002489]
  13. US Food and Drug Administration (FDA) [75F40119C10115]
  14. National Heart, Lung, and Blood Institute (NHLBI) [R01 HL118255]
  15. FDA [CER-2017C39230]
  16. Centers for Disease Control and Prevention (CDC) [1U01DP006369-01]
  17. National Center for Advancing Translational Sciences (NCATS) [1 U54 TR002255]
  18. Health Resources & Services Administration (HRSA) [R40MC29455-01-00]

向作者/读者索取更多资源

This study aimed to evaluate the association between the length of initial opioid prescription and the risk of prolonged opioid use, as well as the potential impact of prescribing limits. The results showed a monotonic increase in the risk of prolonged use with longer prescription duration. Commonly used day supply limits may have a limited impact on reducing prolonged opioid use cases. Any prescribing limits should be balanced with the need for adequate pain management.
Background: In response to concerns about opioid addiction following surgery, many states have implemented laws capping the days supplied for initial postoperative prescriptions. However, few studies have examined changes in the risk of prolonged opioid use associated with the initial amount prescribed. Objective: The objective of this study was to estimate the risk of prolonged opioid use associated with the length of initial opioid prescribed and the potential impact of prescribing limits. Research Design: Using Medicare insurance claims (2007-2017), we identified opioid-naive adults undergoing surgery. Using G-computation methods with logistic regression models, we estimated the risk of prolonged opioid use (>= 1 opioid prescription dispensed in 3 consecutive 30-d windows following surgery) associated with the varying initial number of days supplied. We then estimate the potential reduction in cases of prolonged opioid use associated with varying prescribing limits. Results: We identified 1,060,596 opioid-naive surgical patients. Among the 70.0% who received an opioid for postoperative pain, 1.9% had prolonged opioid use. The risk of prolonged use increased from 0.7% (1 d supply) to 4.4% (15+ d). We estimated that a prescribing limit of 4 days would be associated with a risk reduction of 4.84 (3.59, 6.09)/1000 patients and would be associated with 2255 cases of prolonged use potentially avoided. The commonly used day supply limit of 7 would be associated with a smaller reduction in risk [absolute risk difference=2.04 (-0.17, 4.25)/1000]. Conclusions: The risk of prolonged opioid use following surgery increased monotonically with increasing prescription duration. Common prescribing maximums based on days supplied may impact many patients but are associated with relatively low numbers of reduced cases of prolonged use. Any prescribing limits need to be weighed against the need for adequate pain management.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据